Defunct Company
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
962
NCT01286727
Study to Improve Renal Function After Kidney Transplantation
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2010
Completion: Feb 29, 2016
NCT01561599
Study on Delayed Graft Function Using Paired Kidneys
Start: Aug 31, 2011
Completion: May 31, 2016
NCT01539590
Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
Start: Jul 31, 2012
Completion: Nov 30, 2013
NCT02474667
Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney
Phase: Phase 3
Start: Mar 31, 2016
Completion: Sep 30, 2021
NCT02771509
Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass
Start: Feb 24, 2017
Completion: Aug 31, 2021
NCT04196179
ANG-3070 in Healthy Adult Participants
Phase: Phase 1
Start: Dec 17, 2019
Completion: Mar 10, 2021
NCT04459676
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
Start: Jul 31, 2020
Completion: Apr 30, 2021
NCT04931524
A Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777
Start: May 21, 2021
Completion: Jun 30, 2021
NCT04898907
Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval
Start: Jun 30, 2021
NCT04958187
Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects
Start: Jul 31, 2021
Completion: Oct 31, 2021
NCT04939116
Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
Start: Dec 24, 2021
Completion: Aug 31, 2023
NCT05387785
Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis
Start: Jun 30, 2022
Completion: Nov 30, 2022